Catalyst Wire Dossier Catalyst Wire Dossier

Obeticholic acid and bezafibrate fixed-dose combination

· Intercept Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Obeticholic acid and bezafibrate fixed-dose combination, covering 2026-06-08 to 2026-06-08. Get the full timeline:

Most recent: Clinical Trial Results: To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate [Phase 3]

See pricing